---
aliases: [GALD, Galderma Group]
---
#actor #healthcare #dermatology #switzerland #public

# Galderma

**Global dermatology company** — injectable aesthetics (Restylane, Dysport), prescription dermatology, and consumer skincare (Cetaphil). IPO'd on SIX Swiss Exchange in March 2024 at CHF 53/share (~$39B valuation). [[L'Oréal]] holds 20% stake as of Feb 2026.

---

## Quick stats

| Metric | Value |
|--------|-------|
| Ticker | GALD (SIX Swiss Exchange) |
| HQ | Zug, [[Switzerland]] |
| IPO | March 2024 (SIX) |
| Key brands | Restylane, Dysport, Cetaphil |
| L'Oréal stake | 20% (Feb 2026) |

---

## Related

- [[L'Oréal]] — 20% shareholder, two board seats
- [[Beauty]] — sector hub
